Most CBD research measures what happens after a single dose. Two dog studies looked instead at four weeks of daily dosing, and both found that CBD levels in the blood build up over time, ending well above the first-day levels. Neither found a sign that CBD turns into THC, and the side effects were mild. Dogs are not people, but a human study points the same way, and separate human research shows that a fatty meal can multiply how much CBD the body absorbs.

One dose tells you how CBD starts. It doesn't tell you where it ends up.

Imagine judging a new coffee habit by your first cup. You'd learn how fast the caffeine kicks in and when it wears off. You'd learn nothing about what your body is like after a month of morning coffees.

That is roughly where CBD science stands. Studies that follow a single dose are widely available. They tell us how quickly CBD enters the blood, how high it climbs and how fast it leaves. But people do not take CBD once. They take it night after night, and, surprisingly, there is still a lack of data on what repeated dosing does.

Two studies in dogs help fill that gap. Dogs are one of the standard species in which new compounds are tested over weeks before, or alongside, human studies. What these dogs showed is worth a closer look by anyone who takes CBD regularly.

A pharmacokinetics study is a bloodstream travel diary

Pharmacokinetics, or PK, is the study of what the body does to a compound: how much gets absorbed, where it goes, how it is broken down and how fast it leaves. A PK study gives a dose, then draws small blood samples at set times and measures how much of the compound is present.

Three numbers come out of it, and they are simpler than they sound:

• Peak level (Cmax): the highest concentration the compound reaches in the blood.

• Time to peak (Tmax): how long it takes to get there.

• Total exposure (AUC, or "area under the curve"): plot blood levels over time and measure the area beneath the line. A bigger area means the body saw more of the compound, for longer.

When a dose is repeated before the previous one has fully cleared, levels can stack. Pharmacologists call this accumulation. Eventually intake and clearance balance out, a plateau called steady state.

Here is what each study did:

Day after day, the levels climbed

The headline from both studies is the same: when dogs took CBD every day, the amount in their blood built up over time, well beyond what a single dose produced.

In the beagle study, total exposure after the 28th daily dose was 1.6 to 3.3 times higher than after the first dose, depending on the dose group. Peak levels rose too:

The researchers also measured the "trough," the lowest level just before the next dose. Troughs rose over the first two weeks and then held roughly steady. In other words, the dogs never fully cleared yesterday's CBD before today's arrived, and each new dose started from a higher floor.

The osteoarthritis study found the same pattern with a different route and a smaller dose. CBD levels measured two hours after dosing rose with repeated use, and the highest levels were recorded at the four-week mark.

In both studies, then, the highest CBD levels came after four weeks of daily dosing, not after the first dose. If you only had single-dose data, you would underestimate how much CBD a regular user's body actually sees.

CBD did not turn into THC

A claim circulates online that CBD converts into THC, the compound in cannabis that produces a high, once it reaches the acidic environment of the stomach. It is a tidy story. The data do not support it.

In the osteoarthritis study, no measurable Δ9-THC appeared in the dogs' plasma at any point during four weeks of twice-daily CBD. The question has been tested in people too. In a Phase 1 study of highly purified CBD in healthy adults, THC appeared only at trace levels, mostly below what the lab could quantify, and the authors concluded that this reflected the tiny amount of THC in the product, not conversion in the body. That held at doses far higher than anyone takes for sleep.

The side effects were reassuring as well. In the beagle study, every adverse event was mild and resolved on its own, and events occurred in the placebo group too. The most common at the highest dose was drooling, which cleared within four hours. In the osteoarthritis study, adverse events were likewise mild.

A dog is not a small person

These are dog studies, and that limits what they can tell us. Dogs and humans absorb and process many drugs differently, and they eat, weigh and live differently. The beagles were young and healthy; the second group were older dogs with arthritis. Neither study was designed to measure sleep.

So the right reading is not "this proves what happens in people." It is "this tells us what to look for in people." Whether daily human use builds CBD levels in the same way, and by how much, needs to be determined in human studies.

What this could mean for people who take CBD for sleep

There is early human evidence pointing the same way. In the Phase 1 study in healthy adults, a week of twice-daily purified CBD left blood levels roughly two to two-and-a-half times higher than after the first dose. Those doses were far above what anyone takes for sleep, so the scale may not carry over, but the direction matches the dogs.

That matters for Defined Sleep, which combines 300mg of purified CBD with terpenes. In an FDA-registered, double-blind, placebo-controlled, randomized crossover Phase 2 trial, published in the Journal of Clinical Sleep Medicine and registered at ClinicalTrials.gov (NCT05233761), we measured sleep stages nightly with a validated wearable rather than by questionnaire. People who started with low levels of deep and REM sleep saw up to 2x more of those restorative stages.

The dog data raise a fair question. If daily dosing builds higher overall exposure (what many people loosely call bioavailability), could regular use sustain or strengthen the effect on deep and REM sleep? We don't know yet. It is a hypothesis, not a finding, and it is the kind of question a well-designed repeated-dosing study in people should answer.

Side Note. Your dinner may matter more than you think

CBD dissolves in fat, not water, and what you have eaten changes how much of it your body absorbs. In the same Phase 1 study, taking CBD after a high-fat breakfast raised total exposure about fourfold and peak levels nearly fivefold compared with an empty stomach. A separate study in adults with epilepsy using purified CBD capsules found about four times the total exposure and roughly 14 times the peak level after a high-fat meal.

Note that the beagles in the 28-day study were dosed after an overnight fast, so their levels climbed even without help from a meal. For anyone taking CBD, the practical lesson is that meals are a real source of night-to-night variation, which is one more reason consistency matters.

Old dogs, new questions

One dose of CBD tells you how the story starts. Four weeks of daily doses, at least in dogs, tells a different story: levels that build and then settle at a higher plateau, no sign of conversion to THC, and side effects that stay mild.

The next chapter has to be written in people. Until then, the dogs have done their part. They have shown us where to look. And they are telling us that you should probably take CBD for at least four weeks before you can appreciate any of its benefits.